Latest Insider Transactions at Entera Bio Ltd. (ENTX)
This section provides a real-time view of insider transactions for Entera Bio Ltd. (ENTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Entera Bio Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Entera Bio Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2022
|
Ron Mayron Director |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$14,000
$2.8 P/Share
|
|
Jan 14
2022
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,800
+50.0%
|
$13,600
$2.79 P/Share
|
|
Jan 13
2022
|
Gerald M Ostrov Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.74 P/Share
|
|
Jan 13
2022
|
Yonatan Malca Director |
BUY
Open market or private purchase
|
Direct |
7,232
+50.0%
|
$14,464
$2.74 P/Share
|